Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
MEDDELELSE NR. 252 Storaktionærmeddelelse Storaktionærmeddelelse – AIM International Mutual Funds I henhold til kapitalmarkedslovens § 38 skal det hermed oplyses, at Invesco Ltd. har...
-
ANNOUNCEMENT NO. 252 Major shareholder announcement Major shareholder announcement – AIM International Mutual Funds Pursuant to Section 38 of the Danish Capital Markets Act, it...
-
MEDDELELSE NR. 251 Storaktionærmeddelelse Storaktionærmeddelelse – Invesco Ltd. I henhold til kapitalmarkedslovens § 38 skal det hermed oplyses, at Invesco Ltd. har...
-
ANNOUNCEMENT NO. 251 Major shareholder announcement Major shareholder announcement – Invesco Ltd. Pursuant to Section 38 of the Danish Capital Markets Act, it is hereby announced that...
-
MEDDELELSE NR. 250 5. februar 2024 Delårsrapport for første halvår 2023/24 – Korrektion I forbindelse med den tidligere udsendte delårsrapport for første halvår 2023/24 (meddelelse nr. 249) var der...
-
ANNOUNCEMENT NO. 250 5 February 2024 Interim report for the first half of 2023/24 – Correction In connection with the previously published interim report for the first half of 2023/24 (announcement...
-
MEDDELELSE NR. 249 5. februar 2024 Delårsrapport for første halvår 2023/24 Forventningerne til året fastholdes trods fortsat vanskelige markedsforhold Rasmus Kofoed, CEO:...
-
ANNOUNCEMENT NO. 249 5 February 2024 Interim report for the first half of 2023/24 Full-year guidance maintained despite continued challenging market conditions Rasmus Kofoed,...
-
MEDDELELSE NR. 248 20. december 2023 Martin Glensbjerg får ny rolle i ChemoMetec COO og næstformand for bestyrelsen Martin Glensbjerg har besluttet at trappe ned i ChemoMetec for...
-
ANNOUNCEMENT NO. 248 20 December 2023 Martin Glensbjerg takes up a new role in ChemoMetec COO and deputy chairman of the board Martin Glensbjerg has decided to step down in ChemoMetec to...